Trastuzumab Deruxtecan
Daiichi Sankyo,AstraZeneca
['trastuzumab', 'radio', 'bcsm']
i don't want to bring people down but while the results are great, the destiny of most women with #bcsm worldwide will be not to get trastuzumab deruxtecan since they cannot even access surgery, radiotherapy, endocrine therapy or trastuzumab.
we need to do better #asco22 
Geriatric Oncologist @incmnszmx #gerionc, Global Oncology. @ASCO BOD 20-24, FASCO. PhD @UNAM_MX Opinions my own. No FCOI. ???? https://t.co/GruVow1We8…